Dania Al Jabri, MD
NPI 1174256622ActiveIndividual· Specialist, Research Study· Augusta, GA
Specialist, Research Study (MD) in Augusta, Georgia, with an NPI issued in July 2022. Part D covered 263 prescriptions written in 2024, 79% of them generic. Otsuka America Pharmaceutical, Inc. was the largest of 2 companies reporting payments in 2025, $42.13 in all, mostly food and beverage.
Overview
| NPI | 1174256622 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jul 1, 2022 |
| Last updated in NPPES | Jul 1, 2022 |
| Certified by provider | Jul 1, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Specialist, Research Study Primary | 1744R1102X | — | — |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Order and Referring Only - Internal Medicine (GA) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 263 · 602 30-day fills |
|---|---|
| Patients | 47 |
| Total drug cost | $44,200 |
| Generic share | 79% of claims |
Industry payments (Open Payments)
- 2025$42.13 · 2 payments from 2 companies
- 2024$14.78 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $21.30 | 1 |
| Janssen Biotech, Inc. | $20.83 | 1 |
What the 2025 payments were for
- Food and Beverage$42.13 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records